Literature DB >> 33841612

Cutaneous Plasmacytosis Associated with Ehrlichiosis in an African-American Patient.

Luke Maxfield1,2,3, Jarett Casale1,2,3, Muneeb Shah1,2,3, Mikél E Muse1,2,3, Dana Baigrie1,2,3.   

Abstract

Cutaneous plasmacytosis is a rare disease that presents clinically with multiple red-brown papules and plaques with minimal to no epidermal change. Histopathologic findings include a perivascular dermal infiltration of polyclonal plasma cells. The etiology of cutaneous plasmacytosis is unknown, but hypothesized to be due to persistent or repeated antigenic stimulation. Ehrlichia represents a family of obligate intracellular bacteria that have been associated with the development of plasma cell dyscrasias in the veterinary literature. We present a case of a 67-year-old male patient with the development of progressively worsening cutaneous plasmacytosis following prolonged hospitalization secondary to ehrlichiosis sepsis. The patient initially presented with isolated cutaneous involvement and normal laboratory findings that eventually progressed to include multiple laboratory abnormalities, including anemia, hyperproteinemia, and elevated serum creatinine. Further diagnostic workup was declined by the patient despite evidence of progression to systemic plasmacytosis or multiple myeloma.
Copyright © 2020. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  Cutaneous; chaffeensis; ehrlichia; ehrlichiosis; gamma; gammopathy; human; hypergammaglobulinemia; monoclonal; monocytotropic; multiple; myeloma; plasmacytoma; plasmacytosis; polyclonal; systemic

Year:  2021        PMID: 33841612      PMCID: PMC8021406     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  21 in total

1.  Treatment of facial lesion of cutaneous plasmacytosis with tacrolimus ointment.

Authors:  Hiroyuki Miura; Satoshi Itami; Kunihiko Yoshikawa
Journal:  J Am Acad Dermatol       Date:  2003-12       Impact factor: 11.527

2.  Ehrlichia canis infection in two dogs that emigrated from endemic areas.

Authors:  Kenji Baba; Kazuhito Itamoto; Akiteru Amimoto; Kozue Kitagawa; Hiroko Hiraoka; Takuya Mizuno; Hiroshi Sato; Masaru Okuda
Journal:  J Vet Med Sci       Date:  2011-12-28       Impact factor: 1.267

3.  Thrombocytopathia and light-chain proteinuria in a dog naturally infected with Ehrlichia canis.

Authors:  F Varela; X Font; J E Valladares; J Alberola
Journal:  J Vet Intern Med       Date:  1997 Sep-Oct       Impact factor: 3.333

4.  Multiple myeloma in a dog with multiple concurrent infectious diseases and persistent polyclonal gammopathy.

Authors:  Caroline Geigy; Barbara Riond; Carla Rohrer Bley; Paula Grest; Patrick Kircher; Hans Lutz
Journal:  Vet Clin Pathol       Date:  2012-12-31       Impact factor: 1.180

Review 5.  Ehrlichia under our noses and no one notices.

Authors:  D H Walker
Journal:  Arch Virol Suppl       Date:  2005

Review 6.  Primary cutaneous plasmacytosis: report of three cases and review of the literature.

Authors:  H Uhara; T Saida; S Ikegawa; Y Yamazaki; H Mikoshiba; S Nijoh; K Kitano; C S Koh
Journal:  Dermatology       Date:  1994       Impact factor: 5.366

7.  Monoclonal gammopathy associated with naturally occurring canine ehrlichiosis.

Authors:  E B Breitschwerdt; B J Woody; C A Zerbe; E V De Buysscher; O Barta
Journal:  J Vet Intern Med       Date:  1987 Jan-Mar       Impact factor: 3.333

8.  Systemic plasmacytosis. A syndrome of peculiar multiple skin eruptions, generalized lymphadenopathy, and polyclonal hypergammaglobulinemia.

Authors:  S Watanabe; K Ohara; A Kukita; S Mori
Journal:  Arch Dermatol       Date:  1986-11

Review 9.  Ehrlichia chaffeensis: a prototypical emerging pathogen.

Authors:  Christopher D Paddock; James E Childs
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

10.  Canine Cutaneous Plasmacytosis: 21 Cases (2005-2015).

Authors:  B O Boostrom; A S Moore; C J DeRegis; C Robat; K Freeman; D H Thamm
Journal:  J Vet Intern Med       Date:  2017-05-17       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.